Catherine Sanders

Catherine Sanders

Adaptive Biotechnologies LLC - Seattle / United States
Others
AD Scientific Index ID: 4978713
person_outline Catherine Sanders's MOST POPULAR ARTICLES
1-) Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastomaTF Cloughesy, AY Mochizuki, JR Orpilla, W Hugo, AH Lee, TB Davidson, ...Nature medicine 25 (3), 477-486, 201910252019
2-) Innate immune landscape in early lung adenocarcinoma by paired single-cell analysesY Lavin, S Kobayashi, A Leader, ED Amir, N Elefant, C Bigenwald, ...Cell 169 (4), 750-765. e17, 201710122017
3-) Targeted next generation sequencing identifies markers of response to PD-1 blockadeDB Johnson, GM Frampton, MJ Rioth, E Yusko, Y Xu, X Guo, RC Ennis, ...Cancer immunology research 4 (11), 959-967, 20164332016
4-) ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trialJM Wrangle, V Velcheti, MR Patel, E Garrett-Mayer, EG Hill, JG Ravenel, ...The Lancet Oncology 19 (5), 694-704, 20183972018
5-) Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockadeSJ Dovedi, EJ Cheadle, AL Popple, E Poon, M Morrow, R Stewart, ...Clinical Cancer Research 23 (18), 5514-5526, 20173492017